Testimony & Official Correspondence

FDA’s Flawed Assessment of Bisphenol A Safety Underscores the Need for State and Federal Legislation

An Environmental Working Group (EWG) analysis of FDA’s draft assessment of BPA revealed a number of critical flaws and built in assumptions that biased the agency’s evaluation and ensured that the FDA would find current exposure levels in the population to be safe.

Laboratory studies show BPA harms brain development, raising concerns about its presence in baby bottles and other products that could expose babies and young children.

Key Issues: 

BPA

Download PDF file.

July 7, 2008

Office of Pesticide Programs (OPP)

Regulatory Public Docket (7502P)

Environmental Protection Agency

1200 Pennsylvania Ave., NW.

Washington, DC 20460-0001

Regarding: Triclosan Risk Assessment; Docket EPA–HQ–OPP–2007–0513

To Whom It May Concern:

EWG's Renee Sharp testifies to the California state Senate about the need to remove BPA and lead from children's products.

Key Issues: 

Chemical Policy

Lead

Phthalates

Consumer Products

Children’s Products